PROXYPHYLLINE manufacturers
- Proxyphylline
-
- $41.00 / 500mg
-
2024-11-19
- CAS:603-00-9
- Min. Order:
- Purity: 99.48%
- Supply Ability: 10g
- PROXYPHYLLINE
-
- $35.68 / 1kg
-
2023-11-25
- CAS:603-00-9
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
|
| | PROXYPHYLLINE Basic information |
| | PROXYPHYLLINE Chemical Properties |
| Melting point | 134-136°C | | Boiling point | 487.2±51.0 °C(Predicted) | | density | 1.46±0.1 g/cm3(Predicted) | | storage temp. | Inert atmosphere,Room Temperature | | pka | 14.55±0.20(Predicted) | | form | Solid | | color | White to Off-White | | Water Solubility | 285.7g/L(temperature not stated) | | Merck | 14,7905 | | InChI | InChI=1S/C10H14N4O3/c1-6(15)4-14-5-11-8-7(14)9(16)13(3)10(17)12(8)2/h5-6,15H,4H2,1-3H3 | | InChIKey | KYHQZNGJUGFTGR-UHFFFAOYSA-N | | SMILES | N1(CC(O)C)C2=C(N(C)C(=O)N(C)C2=O)N=C1 | | CAS DataBase Reference | 603-00-9(CAS DataBase Reference) | | NIST Chemistry Reference | Proxyphylline(603-00-9) |
| Hazard Codes | Xn | | Risk Statements | 22 | | Safety Statements | 36 | | WGK Germany | 3 | | RTECS | XH5907500 | | HS Code | 2939.59.0000 |
| | PROXYPHYLLINE Usage And Synthesis |
| Chemical Properties | White Solid | | Uses | A metabolite of Theophylline in human plasma. | | Definition | ChEBI: Proxyphylline is an oxopurine. | | Biological Activity | ki: 82 nm for bovine brain a1 adenosine receptorproxyphylline is an a1 adenosine receptor antagonist.the a1 adenosine receptor, the best characterized purinergic receptor family, can mediate responses via multiple pertussis toxin-sensitive gtp binding proteins to various different effectors. | | in vitro | previous study showed that proxyphylline could selectively antagonize a1 adenosine receptors versus a2 adenosine receptors (ki = 850 μm for platelets) [1]. | | in vivo | in a previous study, rats that were allodynic following the vincristine injections were randomly allocated into four groups. theoesberiven f (a combination of proxyphylline and melilotus extract) was administered to rats. results showed that the decreased paw withdrawal threshold induced by vincristine injection was increased by theoesberiven f treatment and the increased withdrawal frequency to cold stimuli was also reduced by theoesberiven f treatment [2]. | | Purification Methods | Crystallise it from EtOH, aqueous MeOH or EtOAc. Roth Archiv Pharmazie 292 234 1959, Zelnik et al. Bull Soc Chim Fr 1733 1956, Beilstein 26 III/IV 2366.] | | references | [1] u. schwabe, d. ukena and m. j. lohse. xanthine derivatives as antagonists at a1 and a2 adenosine receptors. naunyn-schmiedeberg's arch.pharmacol. 330,212-221 (1985).
[2] s. bang, y. s. kim and s. r. jeong. anti-allodynic effect of theoesberiven f in a vincristine-induced neuropathy model. exp. ther. med. 12(2), 799-803 (2016).
[3] selvig k. pharmacokinetics of proxyphylline in adults after intravenous and oral administration. eur j clin pharmacol. 1981 jan;19(2):149-55. |
| | PROXYPHYLLINE Preparation Products And Raw materials |
|
|
Tag:PROXYPHYLLINE(603-00-9)
Related Product Information
|
|
Diprophylline
diniprofylline
Tazifylline
Xanthinol nicotinate
PROXYPHYLLINE
Theophylline
Xanthinol
1,3-DIMETHYL-7-(OXIRAN-2-YLMETHYL)-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
(S)-Proxyphylline
(R)-Proxyphylline
Xantifibrate
8-CHLORO-7-(3-CHLORO-2-HYDROXYPROPYL)-1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
7-(3-CHLORO-2-HYDROXYPROPYL)-1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
8-BROMO-7-(2-HYDROXYPROPYL)-1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
8-BROMO-7-(3-CHLORO-2-HYDROXYPROPYL)-1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3-DIMETHYL-8-MORPHOLINO-7-(2-OXIRANYLMETHYL)-2,3,6,7-TETRAHYDRO-1H-2,6-PURINEDIONE
8-BROMO-7-(2-HYDROXYBUTYL)-1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
8-(BENZYLAMINO)-7-(3-CHLORO-2-HYDROXYPROPYL)-1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-2,6-PURINEDIONE
|